Total Funding
48
Total FundingSeed raised
Growth Score in past quarter
pts
Heat Score 48 in past quarter
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Capitalizing on our human data-guided target identification and validation platform, we are redefining the landscape of pain management.
- Jackson Brougher: CSO & Co-Founder
- Chris Flores: President, Chief Research & Development OfficerPast Role: Johnson & Johnson Robotics and Digital Solutions, Vice President, Neuroscience Therapeutic Area at Janssen R&D
About the Company
Doloromics, a pain therapeutics discovery company, is building a proprietary platform for the discovery of disease-specific pain mechanisms, biomarkers, and therapeutics.
Women Founded